Welcome to CRYSTAL NAX
Your Trusted Partner for Nucleic Acid eXcellence
Advanced RNA and lipid nanoparticle R&D, from design to delivery
Science-First
Crystal NAX is created and led by scientists and industrial experts with extensive experience in RNA biology and LNP development. We integrate scientific rigor with practical problem-solving, supporting partners across multiple RNA modalities and delivery challenges. This science-first approach enables efficient, informed R&D decisions.
Technology-Driven
Crystal NAX leverages advanced RNA engineering and LNP formulation technologies to address complex R&D questions. Our workflows are modular and customizable, supporting rapid iteration, optimization, and data-driven development. This technology-driven model enables precision without unnecessary rigidity.Quality-Centric
Quality is embedded throughout our project workflows, from experimental design and execution to data analysis and reporting. We emphasize reproducibility, transparency, and scientifically sound datasets that support decision-making and downstream development. High quality outputs are central to every Crystal NAX project.
Client-Focused
We work as a true extension of our clients’ teams, aligning closely with scientific goals, timelines, and constraints. Every project is approached with flexibility, transparency, and responsiveness, enabling customized solutions rather than fixed service packages. Our success is measured by our clients’ progress.
Learn About Our Technology Platforms
Jumpstart your RNA project with the Crystal NAX team by your side
Voice of the clients
News at Crystal NAX
Crystal NAX joins Scientist.com as a supplier
Crystal NAX is now available through Scientist.com, one of the leading scientific procurement marketplaces used by biotech and pharmaceutical R&D teams globally. The listing allows
DNA and RNA Delivery Methods for Gene Therapy Compared
A technical comparison of DNA and RNA gene therapy delivery systems, covering viral vectors, lipid nanoparticles, and non-viral platforms.
Targeted LNP formulation: Antibodies, Aptamers, and Peptides
Ligand choice for targeted LNP shapes more than biology. It determines LNP formulation, immune profile, and analytical burden. Here is how the three main classes compare.
How to Choose the Best Cas9 mRNA for Gene Editing
The best Cas9 mRNA for gene editing is defined by transcript integrity, dsRNA content, capping efficiency, nucleotide modification strategy, and functional validation in a cell-based potency assay. This guide explains what how to evaluate batch data, for researchers working proof of concept to early IND-enabling studies.
How Double-Stranded RNA (dsRNA) Jeopardize RNA Therapeutics
Double-stranded RNA (dsRNA) is an intrinsic IVT impurity that activates immune responses, suppresses translation, and must be controlled within CMC strategy for RNA therapeutics.
RNA Therapeutics Explained: RNA Types, Delivery and Manufacturing
RNA therapeutics include multiple RNA types with distinct mechanisms, but delivery systems and manufacturing determine whether an RNA concept becomes a reproducible, safe medicine.